Showing results (81-90 of 6,003) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|December 21, 2013
The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapyKohei Sano, Takahito Nakajima, Peter L Choyke, et al.
Molecular Cancer Therapeutics|September 6, 2014
Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomicsManuela Gridling, Scott B Ficarro, Florian P Breitwieser, et al.
Molecular Cancer Therapeutics|September 6, 2014
Preclinical profile of the HER2-targeting ADC SYD983/SYD985: introduction of a new duocarmycin-based linker-drug platformWim Dokter, Ruud Ubink, Miranda van der Lee, et al.
Molecular Cancer Therapeutics|September 7, 2014
MEDI-573, alone or in combination with mammalian target of rapamycin inhibitors, targets the insulin-like growth factor pathway in sarcomasHaihong Zhong, Christine Fazenbaker, Shannon Breen, et al.
Molecular Cancer Therapeutics|September 7, 2014
Dual targeting of hypoxia and homologous recombination repair dysfunction in triple-negative breast cancerFrancis W Hunter, Huai-Ling Hsu, Jiechuang Su, et al.
Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.
Molecular Cancer Therapeutics|June 30, 2016
MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin ExpressionShuai Zhu, Chi He, Shijiang Deng, et al.
Molecular Cancer Therapeutics|June 22, 2016
A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric CancerMelissa J LaBonte, Dongyun Yang, Wu Zhang, et al.
Molecular Cancer Therapeutics|October 7, 2015
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified CancersDhara N Amin, Deepika Ahuja, Paul Yaswen, et al.
Molecular Cancer Therapeutics|August 14, 2015
Improvement of Stability and Efficacy of C16Y Therapeutic Peptide via Molecular Self-Assembly into Tumor-Responsive NanoformulationYanping Ding, Tianjiao Ji, Ying Zhao, et al.
Pageof 601